Concepedia

David Martínez‐García

DM

Statistics

Publications

4

Citations

177

H-Index

4

Active since

2016

Affiliations

Universidad de Burgos(Current)

Universitat de Barcelona

Bellvitge University Hospital

Institut d'Investigació Biomédica de Bellvitge

David Martínez‐García is an author at Universidad de Burgos specializing in molecular oncology, medicine, and pharmacology.

Publications per year

2016–2021

4

Publications

4

OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination

Maria Francesca Baietti, Michal Šimíček, Layka Abbasi Asbagh et al. · EMBO Molecular Medicine · 2016 · 104 citations · Full text

Medicine, Genetics, Molecular Biology +17

Novel Indole-based Tambjamine-Analogues Induce Apoptotic Lung Cancer Cell Death through p38 Mitogen-Activated Protein Kinase Activation

Pilar Manuel-Manresa, Luís Korrodi‐Gregório, Elsa Hernando et al. · Molecular Cancer Therapeutics · 2017 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models

David Martínez‐García, Marta Pérez-Hernández, Luís Korrodi‐Gregório et al. · Biomolecules · 2019 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

Multi-Smart and Scalable Bioligands-Free Nanomedical Platform for Intratumorally Targeted Tambjamine Delivery, a Difficult to Administrate Highly Cytotoxic Drug

Marta Pérez-Hernández, Cristina Cuscó, Cristina Benítez-García et al. · Biomedicines · 2021 · 10 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

1–4 of 4